Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

In vivo immunization against autologous glioblastoma-associated antigens


A glioblastoma patient was immunized in vivo with a mixture of autologous and homologous glioblastoma cells coupled to adjuvant peptide and cord-factor analog. Immune activity of peripheral blood lymphocytes was measured in a short-term 51chromium-release assay against autologous tumor target cells. The patient developed direct cell-mediated cytotoxicity against tumor-associated antigens, which appeared to be T-cell mediated.

This is a preview of subscription content, log in to check access.


  1. 1.

    Apuzzo MLJ, Mitchell MS (1981) Immunological aspects of intrinsic glial tumors. J Neurosurg 55:1

  2. 2.

    Bloom HJG, Peckham MJ, Richardson AE, Alexander PA, Payne PM (1973) Glioblastoma multiforme: A controlled trial to assess the value of specific active immunotherapy in patients treated by radical surgery and radiotherapy. Br J Cancer 27:253

  3. 3.

    Dick SJ, Macchi B, Papazoglou S, Oldfield EH, Kornblith PL, Smith BH, Gately MK (1983) Lymphoid cell-glioma interaction enhances cell coat production by human gliomas: novel suppressor mechanism. Science 220:739

  4. 4.

    Eggers AE, Tarmin L, Ginsburg S (1982) Use of covalently bound adjuvant peptide to increase tumor immunogenicity. Cancer Immunol Immunother 12:167

  5. 5.

    Eggers AE, Tarmin L (1984) In vitro immunization against autologous glioblastoma cells coupled to adjuvant peptide. J Neurol Sci 63:147

  6. 6.

    Eggers AE, Tarmin L, Ginsburg S (1984) Use of covalently bound cord factor analog to increase tumor immunogenicity. J Biol Resp Mod 3:413

  7. 7.

    Harvey L, Fox M (1981) Transferral of malignancy as a complication of organ transplantation: an insuperable problem? J Clin Pathol 34:116

  8. 8.

    Lederer E, Adam A, Ciorbaru R, Petit JF, Wietzerbin J (1975) Cell walls of mycobacteria and related organisms: Chemistry and immunostimulant properties. Mol Cell Biochem 7:87

  9. 9.

    Mahaley MS (1978) The immunobiology of human brain tumors. In: Handbook of cancer immunology. Garland Publishing, New York, vol. 3, p 399

  10. 10.

    Mahaley MS, Bigner DD, Dudka LF, Wilds PR, Williams DN, Boudin TW, Whitaker JN, Bynum JN (1983) Immunobiology of primary intracranial tumors, Part 7: Active immunization of patients with anaplastic human glioma cells: a pilot study. J Neurosurg 59:201

  11. 11.

    Ommaya AK (1976) Immunotherapy of gliomas: a review. Adv Neurol 15:337

  12. 12.

    Ponten J, MacIntyre EH (1968) Long-term culture of normal and neoplastic human glia. Acta Path Microbiol Scand 74:465

Download references

Author information

Correspondence to Arnold E. Eggers.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Eggers, A.E., Tarmin, L. & Gamboa, E.T. In vivo immunization against autologous glioblastoma-associated antigens. Cancer Immunol Immunother 19, 43–45 (1985).

Download citation


  • Peptide
  • Cancer Research
  • Target Cell
  • Immune Activity
  • Blood Lymphocyte